Bioline Rx reported $-4.13M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Arca Biopharma USD -36.43M 2M Mar/2026
Bio Path USD -297K 191K Mar/2026
Bioline Rx USD -4.13M 1.79M Jun/2026
Capricor Therapeutics USD -29.16M 2.87M Dec/2025